Cutia Therapeutics (2487.HK)

HKD 6.95

(0.14%)

Long Term Debt Summary of Cutia Therapeutics

  • Cutia Therapeutics's latest annual long term debt in 2023 was 102.97 Million CNY , up 127.32% from previous year.
  • Cutia Therapeutics's latest quarterly long term debt in 2024 Q2 was 40 Million CNY , down 0.0% from previous quarter.
  • Cutia Therapeutics reported annual long term debt of 45.29 Million CNY in 2022, up 98.54% from previous year.
  • Cutia Therapeutics reported annual long term debt of 22.81 Million CNY in 2021, down 0.0% from previous year.
  • Cutia Therapeutics reported quarterly long term debt of 40 Million CNY for 2024 Q2, down 0.0% from previous quarter.
  • Cutia Therapeutics reported quarterly long term debt of 102.97 Million CNY for 2023 FY, up 127.32% from previous quarter.

Annual Long Term Debt Chart of Cutia Therapeutics (2023 - 2021)

Historical Annual Long Term Debt of Cutia Therapeutics (2023 - 2021)

Year Long Term Debt Long Term Debt Growth
2023 102.97 Million CNY 127.32%
2022 45.29 Million CNY 98.54%
2021 22.81 Million CNY 0.0%

Peer Long Term Debt Comparison of Cutia Therapeutics

Name Long Term Debt Long Term Debt Difference
Uni-Bio Science Group Limited 30.61 Million HKD -236.371%
CK Life Sciences Int'l., (Holdings) Inc. 4.27 Billion HKD 97.59%